| pubmed-article:1671469 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1671469 | lifeskim:mentions | umls-concept:C0007807 | lld:lifeskim |
| pubmed-article:1671469 | lifeskim:mentions | umls-concept:C0002395 | lld:lifeskim |
| pubmed-article:1671469 | lifeskim:mentions | umls-concept:C0205462 | lld:lifeskim |
| pubmed-article:1671469 | lifeskim:mentions | umls-concept:C0001044 | lld:lifeskim |
| pubmed-article:1671469 | lifeskim:mentions | umls-concept:C0011900 | lld:lifeskim |
| pubmed-article:1671469 | lifeskim:mentions | umls-concept:C1521991 | lld:lifeskim |
| pubmed-article:1671469 | lifeskim:mentions | umls-concept:C0376315 | lld:lifeskim |
| pubmed-article:1671469 | pubmed:issue | 8739 | lld:pubmed |
| pubmed-article:1671469 | pubmed:dateCreated | 1991-3-13 | lld:pubmed |
| pubmed-article:1671469 | pubmed:abstractText | The possibility that the different molecular forms of acetylcholinesterase (AChE) in cerebrospinal fluid (CSF) which can be revealed by isoelectric focusing may reflect changes in AChE in pathologically affected neurons in Alzheimer's disease was tested in a retrospective study. CSF samples obtained at necropsy from 33 patients with clinically diagnosed dementia, 9 with possible dementia, and 19 without a diagnosis of dementia were examined by isoelectric focusing. An additional band indicating an anomalous molecular form of AChE was present in CSF from 19 of 23 patients with a histological diagnosis of Alzheimer's disease and no other central nervous system disorder but in none of the 19 non-demented patients (without a histological diagnosis of Alzheimer's disease). The band was also present in 2 of 8 patients with histologically defined Alzheimer's disease plus other neurological disorders and in 4 of 8 patients with possible dementia who did not meet histopathological criteria for Alzheimer's disease. The absence of the anomalous form of AChE from the CSF of non-demented patients and its presence in the CSF of the majority of patients with Alzheimer's disease has implications for our understanding of the biological basis of the disease and might form the basis of an antemortem diagnostic test. | lld:pubmed |
| pubmed-article:1671469 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1671469 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1671469 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1671469 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1671469 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:1671469 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1671469 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1671469 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:1671469 | pubmed:issn | 0140-6736 | lld:pubmed |
| pubmed-article:1671469 | pubmed:author | pubmed-author:SmithA DAD | lld:pubmed |
| pubmed-article:1671469 | pubmed:author | pubmed-author:RobinsonJ RJR | lld:pubmed |
| pubmed-article:1671469 | pubmed:author | pubmed-author:EsiriM MMM | lld:pubmed |
| pubmed-article:1671469 | pubmed:author | pubmed-author:McDonaldBB | lld:pubmed |
| pubmed-article:1671469 | pubmed:author | pubmed-author:PriddleJ DJD | lld:pubmed |
| pubmed-article:1671469 | pubmed:author | pubmed-author:NavaratnamD... | lld:pubmed |
| pubmed-article:1671469 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1671469 | pubmed:day | 23 | lld:pubmed |
| pubmed-article:1671469 | pubmed:volume | 337 | lld:pubmed |
| pubmed-article:1671469 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1671469 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1671469 | pubmed:pagination | 447-50 | lld:pubmed |
| pubmed-article:1671469 | pubmed:dateRevised | 2009-9-29 | lld:pubmed |
| pubmed-article:1671469 | pubmed:meshHeading | pubmed-meshheading:1671469-... | lld:pubmed |
| pubmed-article:1671469 | pubmed:meshHeading | pubmed-meshheading:1671469-... | lld:pubmed |
| pubmed-article:1671469 | pubmed:meshHeading | pubmed-meshheading:1671469-... | lld:pubmed |
| pubmed-article:1671469 | pubmed:meshHeading | pubmed-meshheading:1671469-... | lld:pubmed |
| pubmed-article:1671469 | pubmed:meshHeading | pubmed-meshheading:1671469-... | lld:pubmed |
| pubmed-article:1671469 | pubmed:meshHeading | pubmed-meshheading:1671469-... | lld:pubmed |
| pubmed-article:1671469 | pubmed:meshHeading | pubmed-meshheading:1671469-... | lld:pubmed |
| pubmed-article:1671469 | pubmed:meshHeading | pubmed-meshheading:1671469-... | lld:pubmed |
| pubmed-article:1671469 | pubmed:meshHeading | pubmed-meshheading:1671469-... | lld:pubmed |
| pubmed-article:1671469 | pubmed:meshHeading | pubmed-meshheading:1671469-... | lld:pubmed |
| pubmed-article:1671469 | pubmed:meshHeading | pubmed-meshheading:1671469-... | lld:pubmed |
| pubmed-article:1671469 | pubmed:meshHeading | pubmed-meshheading:1671469-... | lld:pubmed |
| pubmed-article:1671469 | pubmed:year | 1991 | lld:pubmed |
| pubmed-article:1671469 | pubmed:articleTitle | Anomalous molecular form of acetylcholinesterase in cerebrospinal fluid in histologically diagnosed Alzheimer's disease. | lld:pubmed |
| pubmed-article:1671469 | pubmed:affiliation | University Department of Pharmacology, Oxford, UK. | lld:pubmed |
| pubmed-article:1671469 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1671469 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1671469 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1671469 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1671469 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1671469 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1671469 | lld:pubmed |
